Form D · Biotechnology
HYDROCISION INC
North Billerica, MA · CIK 0001031309
Offering snapshot reported Apr 1, 2025 · SEC filing
- Reported sold
- $2.53M Offering amount: $3.85M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 1, 2025 | Initial | $2,530,912 | No comparison | 12 | SEC filing |
| Mar 24, 2017 | Initial | $3,000,000 | No comparison | 10 | SEC filing |
| Apr 14, 2010 | Initial | $623,635 | No comparison | 8 | SEC filing |
| Sep 11, 2009 | Amendment | $3,024,300 | No comparison | 11 | SEC filing |
| Nov 25, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 8, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 25, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 12, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 14, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 9, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-542678
Source: Form D, filed Apr 1, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas D. Abert | Executive |
| Jeffrey T Barnes | Director |
| Lew Bennett | Director |
| Alastair Jt Clemow Ph D | Director |
| Alastair J.T. Clemow, Ph.D. | Director |
| Dennis Costello | Director |
| Douglas J Daniels | Director, Executive |
| Howard W. Donnelly | Director |
| Jonathan Fleming | Director |
| Marc E. Goldberg | Director |
| Bryan Grulke | Director |
| James H Hill | Executive |
| Paul Kowalski | Executive |
| Richard J Lim | Director |
| Richard A. Lytle, Iii | Director, Executive |
| John C Miller | Executive |
| Kevin P Staid | Executive |
| Patricia Vanblarcom | Executive |
| Patricia A Van Blarcom | Executive |
| Terry Wall | Director |
| Doug Wall | Director |
| Yu Xiaotong | Director |
| Long Zhan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
267 Boston Road Suite 28
North Billerica, MA, 01862
North Billerica, MA, 01862